Swipe or use the arrows to view product images.
Huaren Pharmaceuticals/Disposable Specimen Retrieval Bag
| Price | $20.00 |
|---|---|
| Min Order | 10000 piece |
| Availability | In Stock |
| Shipping From | Shandong, China |
| Popularity | 374 people viewed |
Model NO.:
QWD-M
Type:
Surgical Instrument
Application:
Abdominal
Feature:
Disposable
Certification:
CE
Group:
All Group
Validity:
2 Years
Trademark:
Huaren
Transport Package:
Carton
Specification:
160ml-320ml
Origin:
China
Product Description
Drug name :Disposable Specimen Retrieval Bag
Description:
This product consists of a handle, a pull rod, a ferrule and a specimen bag.
It is suitable for collecting and removing specimens during clinical endoscopic biopsy or surgery.
Advantages:
The ergonomic handle enables one-handed operation and saves surgical time;The specimen bag has no adhesions and is easy to open, making it easy to put large specimens in. The drawstring is easy to shrink and does not occupy the instrument channel;Reduce debris tissue and liquid residue, reducing the risk of infection.
Specification:
Founded in May 1998, Huaren Pharmaceutical is a modern pharmaceutical and health industry group integrating R&D, production and sales, focusing on medicine, health, medical equipment and medical services.
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
Pharmaceutical packaging materials,Rubber stoppers and APIs are self-produced and self-sold, the price is lower and the quality is more guaranteed.
- Similar Products